Heena Sharma Blog

The total number of coronavirus cases across the world has now crossed the 8-million mark. Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali has claimed that an Ayurvedic medicine developed by the company has been able to cure Covid-19 patients within 5-14 days. Meanwhile, major pharmaceutical companies such as Gilead Sciences, AstraZeneca, Pfizer and Moderna are rushing to find a successful vaccine and some of them have succeeded in many ways. 1. Patanjali's Ayurvedic coronavirus treatment "We are not talking about an immunity booster. We are talking about a cure," said Acharya Balkrishna, managing director of Patanjali. According to the firm, an Ayurvedic medicine developed by the company has been able to cure Covid-19 patients within 5-14 days. The clinical trials were conducted in Indore and in Jaipur after Patanjali secured permission last week. Read More

Ramdev co-founded Patanjali Ayurved on Thursday signalled it had no intent to go slow in consumer goods, launching a slew of products amid sluggish annual sales. In 2017-18 (FY18), Patanjali’s top line grew only 13.6 per cent to Rs 120 billion versus an 88 per cent compounded annual growth rate it saw between FY12 and FY17. On Thursday, the firm forayed into dairy (including cow’s milk, curd, cheese, and butter), packaged water (called Divya Jal) and frozen vegetables (including peas, sweet corn, and potatoes), besides entering segments such as solar panels, and cattle feed. Patanjali also indicated that it was working on a plan of action in textiles and apparels, categories. “We are aiming to have a business of Rs 10 billion next financial year in dairy. This year, we will have a turnover of Rs 5 billion,” Ramdev said at a press meet at the Talkatora Stadium in the capital. ALSO READ: Why Patanjali Ayurved is faltering Patanjali already gets Rs 15 billion annually from cow’